Back to News
Market Impact: 0.2
Tuesday's ETF Movers: GGUS, CRAK
Source: Nasdaq
Market Technicals & FlowsHealthcare & Biotech
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF (GGUS) rose about 2.6% in Tuesday trading, outperforming other ETFs. Viking Therapeutics, a GGUS holding, surged about 33.7%, contributing to the fund's strength; Vicor was also cited as a notable outperformer.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
Ticker Sentiment
GS0.10
VICR0.45
VKTX0.80
More News
- Apollo-backed dental firm vVardis seeks up to $229 million in US IPO
- The AI ‘credit card’ is getting costlier as CoreWeave bond yield tops 16%
- BMO Capital maintains Lyft stock rating amid mixed Q3 results
- Stifel cuts Wynn Resorts stock price target on Strip concerns
- Walt Disney SEVP Horacio Gutierrez sells $2.47M in stock
- Jensen Huang Says AI Needs 1,000 Times More Power. Here's Why Oklo and NuScale Power May Still Suffer.